https://www.selleckchem.com/pr....oducts/epacadostat-i
76 beats/min higher than in the placebo group (95% CI 3.42, 8.1, whereas intergroup differences in systolic and diastolic BP were not statistically significant. The ephedrine-containing product group had a significantly higher mean high-density lipoprotein cholesterol level (MD 2.74 mg/dL; 95% CI 0.94, 4.55), lower mean low-density lipoprotein cholesterol level (MD -5.98 mg/dL; 95% CI -10.97, -0.99), and lower mean triglyceride level (MD -11.25 mg/dL; 95% CI -21.83, -0.68) than the placebo group. Compared with placebo,